1[1]Kapadia SR.Cytokines and heart failure.Cardiol Rev,1999,7 (4):196-206.
2[4]Klein RM,Breuer R,Mundhenke M,et al.Circulating adhesion molecules (CICAM-1,CVCAM-1) in patients with suspected inflammatory heart muscle disease.Z Kardiol,1998,87 (2):84-93.
3[5]Komatsu S,Panes J,Kussell JM,et al.Effects of chronic arterial hypertension on constitutive and induced intercellular adhesion molecule-1 expression in vivo.Hypertension,1997,29 (2):683-689.
6Minamino T, Kitakaze M, Rast P J, et al. Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats[J]. Cardiovasc Drugs Ther 2000,14(5) :533 - 542.
7Groenning B A, Nilsson J C, Sondergaard L, et al. Antiremodeling effects on the left ventricle during, heta - blockade with metoprolol in the treatment of chronic heart failure[J ]. J Am Coil Cardiol, 2000,36 (7) : 2072 - 2080.
8Weber K T,Brilla C G. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin - angiotensin- aldosterone system[ J ]. Circulation, 1991,83(6) : 1849.
9Schmier R E, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension [J ]. J AMA, 1996, 275 ( 19 ) :1507 - 1513.
10Nilsson J C, Groenning B A, Nielsen G, et al. Left ventricular remodeling in the first year after acute myocardial infarction and the predictive and the predictive value of N - terminal pro brain natriuretic peptide[J]. Am Heart J, 2002,143(4) :496 - 702.
